Atlas Trials

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Clinical trial NCT00961883 · COMPLETED

Trial details

NCT number
NCT00961883
Sponsor
HIV Vaccine Trials Network
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections
Start date
2009-08-01
Primary completion
2013-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.